Hoffmann-La Roche Inc.
Hoffmann-La Roche Inc., commonly known as Roche, is a leading global healthcare company headquartered in the United States. Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, with significant operations across North America, Europe, and Asia. The company is renowned for its innovative contributions to oncology, immunology, and infectious diseases, offering a diverse portfolio of prescription medicines and cutting-edge diagnostic tools. Roche's commitment to research and development has led to numerous breakthroughs, positioning it as a market leader in personalised healthcare. Notable achievements include the development of targeted therapies and advanced diagnostics that enhance patient outcomes. With a strong emphasis on innovation and quality, Hoffmann-La Roche Inc. continues to shape the future of healthcare, making a lasting impact on global health.
DitchCarbon Score
How does Hoffmann-La Roche Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hoffmann-La Roche Inc.'s score of 38 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hoffmann-La Roche Inc.'s reported carbon emissions
Hoffmann-La Roche Inc., headquartered in the US, currently does not provide specific carbon emissions data for the most recent year, nor do they outline any formal reduction targets or initiatives. This absence of detailed emissions information suggests that the company may be in the early stages of developing a comprehensive climate strategy. In the context of the pharmaceutical industry, many companies are increasingly committing to ambitious climate goals, including reductions in Scope 1, 2, and 3 emissions. However, without specific data or commitments from Hoffmann-La Roche, it is unclear how they align with these industry standards. As the global focus on sustainability intensifies, it is essential for companies like Hoffmann-La Roche to establish clear climate commitments and transparent reporting on their carbon footprint to meet stakeholder expectations and contribute to broader climate action efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hoffmann-La Roche Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
